Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIF1A | hg38_v1_chr14_+_61695777_61695813 | 0.17 | 3.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_71785167 Show fit | 4.90 |
ENST00000353065.7
|
prokineticin 2 |
|
chr3_-_71785139 Show fit | 4.46 |
ENST00000295619.4
|
prokineticin 2 |
|
chr1_-_8879170 Show fit | 2.35 |
ENST00000489867.2
|
enolase 1 |
|
chr11_+_75768769 Show fit | 2.16 |
ENST00000228027.12
|
diacylglycerol O-acyltransferase 2 |
|
chr11_+_75768718 Show fit | 2.12 |
ENST00000376262.7
|
diacylglycerol O-acyltransferase 2 |
|
chr11_+_75768531 Show fit | 2.03 |
ENST00000604935.5
|
diacylglycerol O-acyltransferase 2 |
|
chr12_+_6868154 Show fit | 1.93 |
ENST00000462761.5
|
triosephosphate isomerase 1 |
|
chr9_-_120714457 Show fit | 1.74 |
ENST00000373930.4
|
multiple EGF like domains 9 |
|
chr18_-_3013114 Show fit | 1.56 |
ENST00000677752.1
|
lipin 2 |
|
chr14_+_92323154 Show fit | 1.52 |
ENST00000532405.6
ENST00000676001.1 ENST00000531433.5 |
solute carrier family 24 member 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 9.4 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
1.1 | 6.3 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.4 | 4.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 2.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 2.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 2.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 2.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 2.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 1.9 | GO:0097186 | amelogenesis(GO:0097186) |
0.4 | 1.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.2 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 4.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 2.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 2.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 1.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.9 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
1.1 | 6.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 4.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 2.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.8 | 2.5 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.7 | 2.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 2.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 1.7 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
0.6 | 1.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 2.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 2.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 7.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 3.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 3.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 2.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |